Deal​‍​‌‍​‍‌​‍​‌‍​‍‌ Overview: Who Bought Whom, for How Much

 

Patient Square Capital has completed the acquisition of Premier, Inc., a leading U.S. healthcare-improvement company, in a transaction valued at $2.6 billion. The deal provides for the purchase of one share of Premier by cash at $28.25, and it is expected that Nasdaq will no longer list Premier stock as of November 25, 2025.

Why Premier Went Private

Based on the information, Premier offers data, analytics, supply-chain solutions, and consulting services to hospitals, suppliers, payers, and policymakers. However, it faced a decline of revenues and cost pressures. Leadership mentioned that changing to private ownership will give Premier more financial freedom, thus technology and business transformation investments could be done without the public market pressures of quarterly results.

What the Acquisition Means for Stakeholders

It was possible for exit stockholders to make a good profit as they were offered a premium of 23.8% over the latest stock average of the company.

Premier, as a firm owned by Patient Square, may be in a position to restructure, invest in new services, and respond to the changing needs of healthcare without being subjected to the short-term public market scrutiny.

This, in turn, could lead to a revived focus on healthcare supply-chain solutions that are supported by technology, as well as on analytics and operational support, in the face of providers being challenged by the need to achieve both cost-saving and efficiency goals.

Bigger Picture: What This Reflects in Healthcare Industry Trends

Across the U.S., healthcare providers and services are struggling with rising costs, adhering to regulatory changes, and shrinking margins. The Merger reflects the strategies of Private Equity and healthcare-focused investment firms, who are leading the charge in consolidating and restructuring companies that serve broad swaths of the industry.

For Premier, the move to a privately-managed health investment portfolio could be a way to secure long-term viability as well as an opportunity to redefine its products in the face of healthcare changes. On the part of investors and industry insiders, it serves as an indication of ongoing consolidation in health services and tools — especially among firms that provide data, supply-chain, and analytics ​‍​‌‍​‍‌​‍​‌‍​‍‌services.